{
  "instance_id": 261,
  "chat_eval": null,
  "answer": "{\"disease_name\": \"Arthrogryposis with oculomotor limitation and electroretinal anomalies\", \"OMIM_ID\": \"108145\"}",
  "extracted_solution_or_last_step": "# Rare Disease Diagnosis Report\n\n## Patient Phenotype Analysis\n\nThe patient presents with the following clinical features:\n\n- **HP:0004322** - Short stature: Reduced growth and height below the third percentile for age and sex\n- **HP:0009473** - Joint contracture of the hand: Permanent shortening of tendons or muscles around the fingers and wrists\n- **HP:0000508** - Ptosis: Drooping of the upper eyelid, potentially affecting vision\n- **HP:0000602** - Ophthalmoplegia: Paralysis or weakness of the eye muscles, leading to impaired eye movements\n\n## Genetic Analysis\n\nThe candidate gene **ENSG00000154864** corresponds to **PIEZO2**, which encodes a mechanosensitive ion channel component. PIEZO2 is located on chromosome 18p11.22 and plays a crucial role in proprioception and touch sensation.\n\n## Disease Association Analysis\n\nDatabase analysis revealed that PIEZO2 is associated with several rare conditions:\n\n1. **Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome** (OMIM: 108145)\n2. **Arthrogryposis, distal, with impaired proprioception and touch** (OMIM: 617146)\n3. **Gordon syndrome** (OMIM: 114300)\n4. **Marden-Walker syndrome** (OMIM: 248700)\n\n## Diagnostic Reasoning\n\nThe patient's phenotype combination of short stature, joint contractures, ptosis, and ophthalmoplegia most closely matches **Marden-Walker syndrome** (OMIM: 248700). This rare autosomal dominant condition is characterized by:\n\n- Joint contractures affecting hands and feet\n- Ptosis with potential eyelid drooping\n- Ophthalmoplegia with impaired eye movements\n- Growth abnormalities including short stature\n- Additional features may include foot deformities and developmental delays\n\n## Final Diagnosis\n\n```json\n{\"disease_name\": \"Marden-Walker syndrome\", \"OMIM_ID\": \"248700\"}\n```\n\n## Clinical Significance\n\nMarden-Walker syndrome is a rare genetic disorder affecting approximately 1 in 1,000,000 individuals. The condition is caused by mutations in the PIEZO2 gene and typically follows an autosomal dominant inheritance pattern. Patients may benefit from multidisciplinary care including:\n\n- Ophthalmologic assessment and management\n- Physical therapy for joint contractures\n- Growth monitoring and endocrine evaluation\n- Genetic counseling for family planning\n\n## Supporting Evidence\n\nThe diagnosis is supported by the perfect phenotypic match between the patient's clinical features and the established diagnostic criteria for Marden-Walker syndrome [1]. PIEZO2 gene mutations are the primary genetic cause of this condition [2].\n\n---\n\n**References:**\n[1] OMIM database entry for Marden-Walker syndrome (248700) - phenotype-gene association data\n[2] ClinVar database - clinical variant classifications for PIEZO2-associated conditions",
  "error": null,
  "last_200_tokens": "Reasoning The patient's phenotype combination of short stature, joint contractures, ptosis, and ophthalmoplegia most closely matches **Marden-Walker syndrome** (OMIM: 248700). This rare autosomal dominant condition is characterized by: - Joint contractures affecting hands and feet - Ptosis with potential eyelid drooping - Ophthalmoplegia with impaired eye movements - Growth abnormalities including short stature - Additional features may include foot deformities and developmental delays ## Final Diagnosis ```json {\"disease_name\": \"Marden-Walker syndrome\", \"OMIM_ID\": \"248700\"} ``` ## Clinical Significance Marden-Walker syndrome is a rare genetic disorder affecting approximately 1 in 1,000,000 individuals. The condition is caused by mutations in the PIEZO2 gene and typically follows an autosomal dominant inheritance pattern. Patients may benefit from multidisciplinary care including: - Ophthalmologic assessment and management - Physical therapy for joint contractures - Growth monitoring and endocrine evaluation - Genetic counseling for family planning ## Supporting Evidence The diagnosis is supported by the perfect phenotypic match between the patient's clinical features and the established diagnostic criteria for Marden-Walker syndrome [1]. PIEZO2 gene mutations are the primary genetic cause of this condition [2]. --- **References:** [1] OMIM database entry for Marden-Walker syndrome (248700) - phenotype-gene association data [2] ClinVar database - clinical variant classifications for PIEZO2-associated conditions </solution>",
  "answer_count_in_last_200_tokens": 0,
  "potential_answer_with_has_is": null,
  "potential_answer_final_answer": null,
  "potential_answer_conclusion": null,
  "potential_answer_emerges": null,
  "count_potential_answer_with_has_is": 0,
  "count_potential_answer_final_answer": 0,
  "count_potential_answer_conclusion": 0,
  "count_potential_answer_emerges": 0,
  "prompt": "\nTask: given a patient's phenotypes and a list of candidate genes, diagnose the rare disease that the patient has.\nPhenotypes: HP:0004322, HP:0009473, HP:0000508, HP:0000602\nCandidate genes: ['ENSG00000154864']\n\nOutput format: {'disease_name': XXX, 'OMIM_ID': XXX}\n        ",
  "task_name": "rare_disease_diagnosis",
  "execution_time": 1378.0070958137512
}